Axia Marlin, Phuong Nguyen Tran, Morgan Dierolf, Molly DeLuca, M. Andrey Joaqui Joaqui, Owen M. Glaser, Angus J. Koller, Eduardo Alucio-Sarduy, Mallory Gork, Dariusz Śmiłowicz, Valérie Pierre, Jonathan W. Engle* and Eszter Boros*,
{"title":"68Ga(III)和45Ti(IV)靶向psma靶向的trenn - cam偶联物对肿瘤靶向成像的评价","authors":"Axia Marlin, Phuong Nguyen Tran, Morgan Dierolf, Molly DeLuca, M. Andrey Joaqui Joaqui, Owen M. Glaser, Angus J. Koller, Eduardo Alucio-Sarduy, Mallory Gork, Dariusz Śmiłowicz, Valérie Pierre, Jonathan W. Engle* and Eszter Boros*, ","doi":"10.1021/acs.bioconjchem.5c0009910.1021/acs.bioconjchem.5c00099","DOIUrl":null,"url":null,"abstract":"<p >Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> is excreted >98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.</p>","PeriodicalId":29,"journal":{"name":"Bioconjugate Chemistry","volume":"36 4","pages":"859–866 859–866"},"PeriodicalIF":4.0000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)\",\"authors\":\"Axia Marlin, Phuong Nguyen Tran, Morgan Dierolf, Molly DeLuca, M. Andrey Joaqui Joaqui, Owen M. Glaser, Angus J. Koller, Eduardo Alucio-Sarduy, Mallory Gork, Dariusz Śmiłowicz, Valérie Pierre, Jonathan W. Engle* and Eszter Boros*, \",\"doi\":\"10.1021/acs.bioconjchem.5c0009910.1021/acs.bioconjchem.5c00099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> is excreted >98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.</p>\",\"PeriodicalId\":29,\"journal\":{\"name\":\"Bioconjugate Chemistry\",\"volume\":\"36 4\",\"pages\":\"859–866 859–866\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioconjugate Chemistry\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.bioconjchem.5c00099\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioconjugate Chemistry","FirstCategoryId":"1","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.bioconjchem.5c00099","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)
Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes 68Ga3+ and 45Ti4+, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [45Ti][Ti(TREN-CAM-hex-EuE)]2–, [45Ti][Ti(TREN-CAM-hex-KuE)]2–, and [68Ga][Ga(TREN-CAM-hex-KuE)]3– form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [45Ti][Ti(TREN-CAM-hex-EuE)]2–, [45Ti][Ti(TREN-CAM-hex-KuE)]2– and [68Ga][Ga(TREN-CAM-hex-KuE)]3– respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [45Ti][Ti(TREN-CAM-hex-KuE)]2– complex is observed when compared with that of [68Ga][Ga(TREN-CAM-hex-KuE)]3– as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [68Ga][Ga(TREN-CAM-hex-KuE)]3– is excreted >98% intact, while [45Ti][Ti(TREN-CAM-hex-KuE)]2– exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for 68Ga3+ and 45Ti4+ isotopes.
期刊介绍:
Bioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials. The mission of the journal is to communicate to advances in fields including therapeutic delivery, imaging, bionanotechnology, and synthetic biology. Bioconjugate Chemistry is intended to provide a forum for presentation of research relevant to all aspects of bioconjugates, including the preparation, properties and applications of biomolecular conjugates.